Inhaled drug combo may prevent lung damage in transplant kids
NCT ID NCT04655508
First seen Sep 30, 2025 · Last updated May 31, 2026 · Updated 32 times
Summary
This study looked at whether a daily inhaled medicine (fluticasone and salmeterol) could improve lung function in children aged 6–17 who had a stem cell transplant and showed early signs of lung decline. The goal was to prevent a serious lung condition called bronchiolitis obliterans. The trial was stopped early, but earlier research suggests this approach might help stabilize breathing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Houdouin véronique
Paris, 75019, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.